+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Erectile Dysfunction Drugs Market Research Report by Drug, by Mode of Administration, by End-User - Global Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 4989691
  • Report
  • March 2021
  • Region: Global
  • 182 pages
  • 360iResearch™
UP TO OFF
until Jun 30th 2021
1 of 4
The Global Erectile Dysfunction Drugs Market to Grow USD 2,682.61 Million by 2025, at a CAGR of 6.38%

FEATURED COMPANIES

  • Apricus Biosciences Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • GlaxoSmithKline PLC
  • Novartis International AG
  • MORE
Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Erectile Dysfunction Drugs Market is expected to grow from USD 1,968.40 Million in 2020 to USD 2,682.61 Million by the end of 2025.
2. The Global Erectile Dysfunction Drugs Market is expected to grow from EUR 1,725.93 Million in 2020 to EUR 2,352.16 Million by the end of 2025.
3. The Global Erectile Dysfunction Drugs Market is expected to grow from GBP 1,534.36 Million in 2020 to GBP 2,091.08 Million by the end of 2025.
4. The Global Erectile Dysfunction Drugs Market is expected to grow from JPY 210,079.00 Million in 2020 to JPY 286,302.93 Million by the end of 2025.
5. The Global Erectile Dysfunction Drugs Market is expected to grow from AUD 2,858.39 Million in 2020 to AUD 3,895.51 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Erectile Dysfunction Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug, the Erectile Dysfunction Drugs Market is examined across Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra), Tadalafil (Cialis), and Vardenafil (Levitra, Staxyn).

Based on Mode of Administration, the Erectile Dysfunction Drugs Market is examined across Injections, Oral, and Topical.

Based on End-User, the Erectile Dysfunction Drugs Market is examined across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.

Based on Geography, the Erectile Dysfunction Drugs Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Erectile Dysfunction Drugs Market including Apricus Biosciences Inc., Aurobindo Pharma Ltd, Bayer AG, Cipla Ltd, Cristalia Produtos Quimicos Farmaceuticos Ltd., Dong-A Pharmaceutical Co. Ltd., Dr. Reddys Laboratories Ltd, Eli Lilly and Company, Endo International PLC, Ferring Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc, Meda Pharmaceuticals, Inc., Metuchen Pharmaceuticals LLC, Mylan N.V., Novartis International AG, Pfizer, Inc., Promedon HQ, S.K. Chemicals Co. Ltd., Teva Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd, and Vivus, Inc..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Erectile Dysfunction Drugs Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Erectile Dysfunction Drugs Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Erectile Dysfunction Drugs Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Erectile Dysfunction Drugs Market?
4. What is the competitive strategic window for opportunities in the Global Erectile Dysfunction Drugs Market?
5. What are the technology trends and regulatory frameworks in the Global Erectile Dysfunction Drugs Market?
6. What are the modes and strategic moves considered suitable for entering the Global Erectile Dysfunction Drugs Market?
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Apricus Biosciences Inc.
  • Bayer AG
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • GlaxoSmithKline PLC
  • Novartis International AG
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Drug Outlook
3.4. Mode of Administration Outlook
3.5. End-User Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in patient awareness and education levels
5.1.1.2. Growing portion of geriatric population
5.1.1.3. Rising adoption of a sedentary lifestyle and incidence of lifestyle diseases
5.1.2. Restraints
5.1.2.1. Side effects associated with the erectile dysfunction drugs
5.1.3. Opportunities
5.1.3.1. Government reforms and public awareness initiatives in developing nations
5.1.3.2. R&D focused on developments of effective therapies and treatments for erectile dysfunction
5.1.4. Challenges
5.1.4.1. Availability of cost-effective counterfeit drugs
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Global Erectile Dysfunction Drugs Market, By Drug
6.1. Introduction
6.2. Avanafil (Stendra)
6.3. Muse Suppository (Alprostadil)
6.4. Sildenafil (Viagra)
6.5. Tadalafil (Cialis)
6.6. Vardenafil (Levitra, Staxyn)

7. Global Erectile Dysfunction Drugs Market, By Mode of Administration
7.1. Introduction
7.2. Injections
7.3. Oral
7.4. Topical

8. Global Erectile Dysfunction Drugs Market, By End-User
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Erectile Dysfunction Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Erectile Dysfunction Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand

11. Europe, Middle East & Africa Erectile Dysfunction Drugs Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Apricus Biosciences Inc.
13.2. Aurobindo Pharma Ltd
13.3. Bayer AG
13.4. Cipla Ltd
13.5. Cristalia Produtos Quimicos Farmaceuticos Ltd.
13.6. Dong-A Pharmaceutical Co. Ltd.
13.7. Dr. Reddys Laboratories Ltd
13.8. Eli Lilly and Company
13.9. Endo International PLC
13.10. Ferring Pharmaceuticals
13.11. Futura Medical PLC
13.12. GlaxoSmithKline PLC
13.13. Johnson & Johnson Services, Inc
13.14. Meda Pharmaceuticals, Inc.
13.15. Metuchen Pharmaceuticals LLC
13.16. Mylan N.V.
13.17. Novartis International AG
13.18. Pfizer, Inc.
13.19. Promedon HQ
13.20. S.K. Chemicals Co. Ltd.
13.21. Teva Pharmaceutical Industries Ltd
13.22. Torrent Pharmaceuticals Ltd
13.23. Vivus, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing

List of Figures
Figure 1. Global Erectile Dysfunction Drugs Market: Research Process
Figure 2. Global Erectile Dysfunction Drugs Market: Research Execution
Figure 3. Global Erectile Dysfunction Drugs Market Size, 2020 Vs 2025 (USD Million)
Figure 4. Global Erectile Dysfunction Drugs Market Size, by Drug, 2020 (USD Million)
Figure 5. Global Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2020 (USD Million)
Figure 6. Global Erectile Dysfunction Drugs Market Size, by End-User, 2020 (USD Million)
Figure 7. Global Erectile Dysfunction Drugs Market Size, by Geography, 2020 (USD Million)
Figure 8. Global Erectile Dysfunction Drugs Market Size, 2018-2025 (USD Million)
Figure 9. Global Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 10. Global Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 11. Competitive Strategic Window for Global Erectile Dysfunction Drugs Market Size, by Geography, 2025
Figure 12. Global Erectile Dysfunction Drugs Market: Market Dynamics
Figure 13. Global Erectile Dysfunction Drugs Market: Porters Five Forces Analysis
Figure 14. Global Erectile Dysfunction Drugs Market Size, by Drug, 2020 Vs 2025 (%)
Figure 15. Global Erectile Dysfunction Drugs Market Size, by Drug, 2020 Vs 2025 (USD Million)
Figure 16. Competitive Strategic Window for Global Erectile Dysfunction Drugs Market Size, by Drug, 2025
Figure 17. Global Erectile Dysfunction Drugs Market Size, by Avanafil (Stendra), 2020 Vs 2025 (USD Million)
Figure 18. Global Erectile Dysfunction Drugs Market Size, by Muse Suppository (Alprostadil), 2020 Vs 2025 (USD Million)
Figure 19. Global Erectile Dysfunction Drugs Market Size, by Sildenafil (Viagra), 2020 Vs 2025 (USD Million)
Figure 20. Global Erectile Dysfunction Drugs Market Size, by Tadalafil (Cialis), 2020 Vs 2025 (USD Million)
Figure 21. Global Erectile Dysfunction Drugs Market Size, by Vardenafil (Levitra, Staxyn), 2020 Vs 2025 (USD Million)
Figure 22. Global Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2020 Vs 2025 (%)
Figure 23. Global Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2020 Vs 2025 (USD Million)
Figure 24. Competitive Strategic Window for Global Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2025
Figure 25. Global Erectile Dysfunction Drugs Market Size, by Injections, 2020 Vs 2025 (USD Million)
Figure 26. Global Erectile Dysfunction Drugs Market Size, by Oral, 2020 Vs 2025 (USD Million)
Figure 27. Global Erectile Dysfunction Drugs Market Size, by Topical, 2020 Vs 2025 (USD Million)
Figure 28. Global Erectile Dysfunction Drugs Market Size, by End-User, 2020 Vs 2025 (%)
Figure 29. Global Erectile Dysfunction Drugs Market Size, by End-User, 2020 Vs 2025 (USD Million)
Figure 30. Competitive Strategic Window for Global Erectile Dysfunction Drugs Market Size, by End-User, 2025
Figure 31. Global Erectile Dysfunction Drugs Market Size, by Hospital Pharmacies, 2020 Vs 2025 (USD Million)
Figure 32. Global Erectile Dysfunction Drugs Market Size, by Online Pharmacies, 2020 Vs 2025 (USD Million)
Figure 33. Global Erectile Dysfunction Drugs Market Size, by Retail Pharmacies, 2020 Vs 2025 (USD Million)
Figure 34. Americas Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 35. Americas Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 36. Competitive Strategic Window for Americas Erectile Dysfunction Drugs Market Size, by Geography, 2025
Figure 37. Argentina Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 38. Brazil Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 39. Canada Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 40. Mexico Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 41. United States Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 42. Asia-Pacific Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 43. Asia-Pacific Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 44. Competitive Strategic Window for Asia-Pacific Erectile Dysfunction Drugs Market Size, by Geography, 2025
Figure 45. Australia Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 46. China Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 47. India Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 48. Indonesia Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 49. Japan Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 50. Malaysia Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 51. Philippines Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 52. South Korea Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 53. Thailand Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 54. Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (%)
Figure 55. Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by Geography, 2020 Vs 2025 (USD Million)
Figure 56. Competitive Strategic Window for Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by Geography, 2025
Figure 57. France Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 58. Germany Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 59. Italy Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 60. Netherlands Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 61. Qatar Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 62. Russia Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 63. Saudi Arabia Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 64. South Africa Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 65. Spain Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 66. United Arab Emirates Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 67. United Kingdom Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD Million)
Figure 68. Global Erectile Dysfunction Drugs Market: Fpnv Positioning Matrix
Figure 69. Global Erectile Dysfunction Drugs Market: Market Share Analysis
Figure 70. Global Erectile Dysfunction Drugs Market: Competitor SWOT Analysis
Figure 71. Competitive Scenario Analysis in Global Erectile Dysfunction Drugs Market, by Type

List of Tables
Table 1. Currency Conversion Rates
Table 2. Global Erectile Dysfunction Drugs Market Size, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 3. Global Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 4. Global Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 5. Global Erectile Dysfunction Drugs Market Size, by Avanafil (Stendra), by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 6. Global Erectile Dysfunction Drugs Market Size, by Muse Suppository (Alprostadil), by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 7. Global Erectile Dysfunction Drugs Market Size, by Sildenafil (Viagra), by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 8. Global Erectile Dysfunction Drugs Market Size, by Tadalafil (Cialis), by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 9. Global Erectile Dysfunction Drugs Market Size, by Vardenafil (Levitra, Staxyn), by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 10. Global Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 11. Global Erectile Dysfunction Drugs Market Size, by Injections, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 12. Global Erectile Dysfunction Drugs Market Size, by Oral, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 13. Global Erectile Dysfunction Drugs Market Size, by Topical, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 14. Global Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 15. Global Erectile Dysfunction Drugs Market Size, by Hospital Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 16. Global Erectile Dysfunction Drugs Market Size, by Online Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 17. Global Erectile Dysfunction Drugs Market Size, by Retail Pharmacies, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 18. Americas Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 19. Americas Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 20. Americas Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 21. Americas Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 22. Argentina Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 23. Argentina Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 24. Argentina Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 25. Brazil Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 26. Brazil Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 27. Brazil Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 28. Canada Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 29. Canada Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 30. Canada Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 31. Mexico Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 32. Mexico Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 33. Mexico Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 34. United States Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 35. United States Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 36. United States Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 37. Asia-Pacific Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 38. Asia-Pacific Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 39. Asia-Pacific Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 40. Asia-Pacific Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 41. Australia Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 42. Australia Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 43. Australia Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 44. China Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 45. China Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 46. China Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 47. India Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 48. India Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 49. India Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 50. Indonesia Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 51. Indonesia Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 52. Indonesia Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 53. Japan Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 54. Japan Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 55. Japan Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 56. Malaysia Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 57. Malaysia Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 58. Malaysia Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 59. Philippines Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 60. Philippines Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 61. Philippines Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 62. South Korea Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 63. South Korea Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 64. South Korea Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 65. Thailand Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 66. Thailand Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 67. Thailand Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 68. Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by Geography, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 69. Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 70. Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 71. Europe, Middle East & Africa Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 72. France Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 73. France Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 74. France Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 75. Germany Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 76. Germany Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 77. Germany Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 78. Italy Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 79. Italy Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 80. Italy Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 81. Netherlands Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 82. Netherlands Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 83. Netherlands Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 84. Qatar Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 85. Qatar Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 86. Qatar Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 87. Russia Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 88. Russia Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 89. Russia Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 90. Saudi Arabia Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 91. Saudi Arabia Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 92. Saudi Arabia Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 93. South Africa Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 94. South Africa Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 95. South Africa Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 96. Spain Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 97. Spain Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 98. Spain Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 99. United Arab Emirates Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 100. United Arab Emirates Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 101. United Arab Emirates Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 102. United Kingdom Erectile Dysfunction Drugs Market Size, by Drug, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 103. United Kingdom Erectile Dysfunction Drugs Market Size, by Mode of Administration, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 104. United Kingdom Erectile Dysfunction Drugs Market Size, by End-User, 2018-2025 (USD/EUR/GBP/JPY/AUD Million)
Table 105. Global Erectile Dysfunction Drugs Market: Scores
Table 106. Global Erectile Dysfunction Drugs Market: Business Strategy
Table 107. Global Erectile Dysfunction Drugs Market: Product Satisfaction
Table 108. Global Erectile Dysfunction Drugs Market: Ranking
Table 109. Global Erectile Dysfunction Drugs Market: Merger & Acquisition
Table 110. Global Erectile Dysfunction Drugs Market: Agreement, Collaboration, & Partnership
Table 111. Global Erectile Dysfunction Drugs Market: New Product Launch & Enhancement
Table 112. Global Erectile Dysfunction Drugs Market: Investment & Funding
Table 113. Global Erectile Dysfunction Drugs Market: Award, Recognition, & Expansion
Table 114. Global Erectile Dysfunction Drugs Market: License & Pricing
Note: Product cover images may vary from those shown
3 of 4
  • Apricus Biosciences Inc.
  • Aurobindo Pharma Ltd
  • Bayer AG
  • Cipla Ltd
  • Cristalia Produtos Quimicos Farmaceuticos Ltd.
  • Dong-A Pharmaceutical Co. Ltd.
  • Dr. Reddys Laboratories Ltd
  • Eli Lilly and Company
  • Endo International PLC
  • Ferring Pharmaceuticals
  • Futura Medical PLC
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc
  • Meda Pharmaceuticals, Inc.
  • Metuchen Pharmaceuticals LLC
  • Mylan N.V.
  • Novartis International AG
  • Pfizer, Inc.
  • Promedon HQ
  • S.K. Chemicals Co. Ltd.
  • Teva Pharmaceutical Industries Ltd
  • Torrent Pharmaceuticals Ltd
  • Vivus, Inc.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll